The Recall Desk

Category

Drug recalls

FDA recalls of prescription and over-the-counter drugs.

About drug recalls

FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.

The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.

If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.

251–275 of 5132

  • HighFDA (Drugs)·D-0469-2026·2026-04-22

    [pending] QUALITY CHOICE (COUGH DROPS MENTHOL)

    Pending LLM rewrite. Source: FDA_DRUG D-0469-2026.

    Product
    QUALITY CHOICE — QUALITY CHOICE (COUGH DROPS MENTHOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0462-2026·2026-04-22

    [pending] MGC HEALTH (COUGH DROPS HONEY)

    Pending LLM rewrite. Source: FDA_DRUG D-0462-2026.

    Product
    MGC HEALTH — MGC HEALTH (COUGH DROPS HONEY)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0483-2026·2026-04-22

    [pending] EPINEPHRINE (EPINEPHRINE)

    Pending LLM rewrite. Source: FDA_DRUG D-0483-2026.

    Product
    EPINEPHRINE — EPINEPHRINE (EPINEPHRINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0436-2026·2026-04-15

    [pending] DEXTROSE (DEXTROSE MONOHYDRATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0436-2026.

    Product
    DEXTROSE — DEXTROSE (DEXTROSE MONOHYDRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0427-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0427-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0432-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0432-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0435-2026·2026-04-15

    [pending] DEXTROSE (DEXTROSE MONOHYDRATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0435-2026.

    Product
    DEXTROSE — DEXTROSE (DEXTROSE MONOHYDRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0444-2026·2026-04-15

    [pending] XANAX (ALPRAZOLAM)

    Pending LLM rewrite. Source: FDA_DRUG D-0444-2026.

    Product
    XANAX — XANAX (ALPRAZOLAM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0425-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0425-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0434-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0434-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0426-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0426-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0447-2026·2026-04-15

    [pending] OMNIPAQUE (IOHEXOL)

    Pending LLM rewrite. Source: FDA_DRUG D-0447-2026.

    Product
    OMNIPAQUE — OMNIPAQUE (IOHEXOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0446-2026·2026-04-15

    [pending] ISOTRETINOIN (ISOTRETINOIN)

    Pending LLM rewrite. Source: FDA_DRUG D-0446-2026.

    Product
    ISOTRETINOIN — ISOTRETINOIN (ISOTRETINOIN)
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0443-2026·2026-04-15

    [pending] ARTIFICIAL TEARS (GLYCERIN)

    Pending LLM rewrite. Source: FDA_DRUG D-0443-2026.

    Product
    ARTIFICIAL TEARS — ARTIFICIAL TEARS (GLYCERIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0431-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0431-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0445-2026·2026-04-15

    [pending] ISOTRETINOIN (ISOTRETINOIN)

    Pending LLM rewrite. Source: FDA_DRUG D-0445-2026.

    Product
    ISOTRETINOIN — ISOTRETINOIN (ISOTRETINOIN)
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0448-2026·2026-04-15

    [pending] OMNIPAQUE (IOHEXOL)

    Pending LLM rewrite. Source: FDA_DRUG D-0448-2026.

    Product
    OMNIPAQUE — OMNIPAQUE (IOHEXOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0423-2026·2026-04-15

    [pending] LANREOTIDE ACETATE (LANREOTIDE ACETATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0423-2026.

    Product
    LANREOTIDE ACETATE — LANREOTIDE ACETATE (LANREOTIDE ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0474-2026·2026-04-15

    [pending] CLONIDINE TRANSDERMAL SYSTEM (CLONIDINE)

    Pending LLM rewrite. Source: FDA_DRUG D-0474-2026.

    Product
    CLONIDINE TRANSDERMAL SYSTEM — CLONIDINE TRANSDERMAL SYSTEM (CLONIDINE)
    Category
    Drug
    Distribution
    0 states
  • HighFDA (Drugs)·D-0422-2026·2026-04-15

    [pending] LANREOTIDE ACETATE (LANREOTIDE ACETATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0422-2026.

    Product
    LANREOTIDE ACETATE — LANREOTIDE ACETATE (LANREOTIDE ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0430-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0430-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0424-2026·2026-04-15

    [pending] SODIUM CHLORIDE (SODIUM CHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0424-2026.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide

Looking for a different category? Browse all recalls.